Healthcare Facilities & Services

Page 1

Genesis Genetics Asia to issue new shares through private placement

Tuesday, 17 Mar 2015 05:11am EDT

Genesis Genetics Asia Corp:To issue up to 10 million new shares through private placement.Proceeds to be used to enrich operating funds and introduce strategic investors.

Genesis Genetics Asia withdraws private placement new share issuance for 2014

Tuesday, 17 Mar 2015 05:08am EDT

Genesis Genetics Asia Corp:Withdraws private placement new share issuance for 2014.Plan disclosed on June 6, 2014.

Asian American Medical Group Ltd issues shares

Friday, 13 Mar 2015 03:51am EDT

Asian American Medical Group Ltd:Issues 30,000,000 fully paid ordinary shares at A$0.10.

Sonic Healthcare Limited issues ordinary shares

Wednesday, 11 Mar 2015 01:11am EDT

Sonic Healthcare Limited:Issues 560,000 fully paid ordinary shares.

BioScrip raises $62.5 million in private placement of convertible preferred stock and announces plan for $20 million rights offering

Monday, 9 Mar 2015 09:34am EDT

BioScrip Inc:Says sale of $62.5 million in Series A Convertible Preferred Stock to Coliseum Capital Management, LLC and affiliated funds.The Preferred Stock is convertible into 12,088,975 shares of BioScrip's common stock at conversion price of $5.17 per share, which was the closing price of BioScrip's common stock on NASDAQ Global Market on March 6.Dividends on the Preferred Stock will be payable quarterly at an annual rate of 8.5 pct if paid in cash or 11.5 pct if accrued.As part of the transaction, BioScrip issued to Coliseum Capital warrants for an aggregate of 3.6 million shares of BioScrip stock.Warrants for 1.8 million shares are exercisable at $5.295 per share and warrants for 1.8 million shares are exercisable at $6.596 per share.In addition, BioScrip intends to conduct a registered rights offering to allow all of BioScrip's existing stockholders of record, on date to be determined by the Board.The non-transferable right to purchase their pro rata share of $20.0 million of Preferred Stock and warrants on same terms as completed private placement to Coliseum Capital.Proceeds from private placement will be used primarily to reduce BioScrip's outstanding indebtedness.

Asian American Medical Group Ltd announces placement of new shares

Thursday, 5 Mar 2015 11:30pm EST

Asian American Medical Group Ltd:Announces that it has entered into a placement agreement with a group of sophisticated investors.Says each subscriber will subscribe for 10,000,000 new ordinary shares to be issued, or a total of 30,000,000 new ordinary shares.Says representing 14.3 pct of the existing issued and paid up share capital and 12.5 pct of the new enlarged share capital, at A$0.10 per share, representing the closing price on March 4.Says the company will raise gross proceeds of A$3.0 million from the Placement to be used for business diversification and expansion into new healthcare-related businesses and general corporate working capital purposes.

CareTech Holdings PLC announces issue of equity

Tuesday, 3 Mar 2015 08:45am EST

CareTech Holdings PLC:Issues 10,000,000 Placing Shares, as described in its announcement of Feb. 27 of a Placing to raise gross proceeds of 21.0 mln pounds.

Caretech Holdings Plc announces placing

Friday, 27 Feb 2015 02:02am EST

Caretech Holdings Plc:Conditional placing of 10,000,000 placing shares at a price of 210 pence per placing share to raise 21.0 mln pounds gross.The company initially set out to raise 15.0 mln pounds (gross), however the size of the fundraising increased due to demand levels.

Signal Genetics announces closing of $9,000,000 public offering

Monday, 23 Feb 2015 08:31am EST

Signal Genetics Inc:Says closing of its previously announced underwritten public offering of 3,214,285 shares of its common stock at a price to the public of $2.80 per share.Gross proceeds raised by Signal in the offering were $9,000,000, before deducting underwriting discounts and commissions and other estimated offering expenses.Grants the underwriters a 45-day option to purchase up to 482,142 shares of common stock to cover over-allotments, if any.Aegis Capital Corp. and Chardan Capital Markets, LLC acted as joint book-running managers for the offering.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Market Edge
$10.00
Provider: Market Edge
$10.00
Provider: Auerbach Grayson & Co., Inc.
$25.00
Provider: Auerbach Grayson & Co., Inc.
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.